Does the introduction of prostate multiparametric magnetic resonance imaging into the active surveillance protocol for localized prostate cancer improve patient re‐classification?

Objectives To determine whether replacement of protocol‐driven repeat prostate biopsy ( PB ) with multiparametric magnetic resonance imaging (mp MRI ) ± repeat targeted prostate biopsy ( TB ) when evaluating men on active surveillance ( AS ) for low‐volume, low‐ to intermediate‐risk prostate cancer ( PC a) altered the likelihood of or time to treatment, or reduced the number of repeat biopsies required to trigger treatment. Patients and Methods...